Hospital News and Research

RSS

Scientists identify gene mutation that causes color blindness

A rare eye disorder marked by color blindness, light sensitivity, and other vision problems can result from a newly discovered gene mutation identified by an international research team, including scientists from Columbia University Medical Center.

3 Jun 2015

Researchers explore association between SSRI exposure in late pregnancy and risk of PPHN

Use of antidepressants late in pregnancy has been controversial since the FDA issued a Public Health Advisory in 2006 warning that the use of antidepressants in late pregnancy may increase risk of persistent pulmonary hypertension of the newborn (PPHN), a condition that typically occurs in term or near-term infants and presents within hours of birth with severe respiratory failure requiring intubation and mechanical ventilation.

2 Jun 2015

NW Bio releases promising new data on DCVax-Direct Phase I trial for inoperable solid tumors

Northwest Biotherapeutics, a U.S. biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, over the weekend in Chicago released promising new data on their Phase I trial of DCVax-Direct for direct injection into all types of inoperable solid tumors.

2 Jun 2015

Elusys’ Anthim BLA to treat inhalational anthrax accepted for review by the FDA

Elusys Therapeutics, Inc. today announced the U.S. Food and Drug Administration has accepted for filing and review its Biologics License Application for Anthim® (obiltoxaximab) for the treatment and prevention of inhalational anthrax, a top bioterror threat which was submitted on March 20, 2015. Anthim is a candidate for future acquisition into the Strategic National Stockpile, the U.S. government's repository of critical medical supplies for biowarfare preparedness.

2 Jun 2015

Vitamin D and calcium supplements may not help relieve menopausal symptoms, reveals study

Women who took vitamin D and calcium supplements had the same number of menopausal symptoms as women who did not take the supplements, according to a study published today in Maturitas, the official journal of the European Menopause and Andropause Society.

2 Jun 2015

Intermountain Precision Genomics: Precision medicine can benefit advanced cancer patients without increasing costs

Two new studies conducted by Intermountain Healthcare’s Intermountain Precision Genomics reveal that precision medicine can improve survival in advanced cancer patients – and do so without increasing costs.

2 Jun 2015

ESMO-MCBS tool will help oncology clinicians evaluate most effective anti-cancer medicines

ESMO announced the publication of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS), a tool to assist oncology clinicians in evaluating the most effective anti-cancer medicines for their patients.

2 Jun 2015

ASCO 2015: Novartis presents data on Zykadia and Tafinlar studies for non-small cell lung cancer

Novartis today announced new data from two Phase II studies of Zykadia (ceritinib), as well as one Phase II study of Tafinlar® (dabrafenib) in combination with Mekinist (trametinib) in certain patients with non-small cell lung cancer.

2 Jun 2015

New treatment option for postmenopausal women with non-invasive breast cancer

Anastrozole provides a significant benefit compared with tamoxifen in preventing recurrence after a lumpectomy and radiation therapy in postmenopausal women ages 60 years or younger who had DCIS (ductal carcinoma in situ), a common diagnosis of non-invasive breast cancer. In women over age 60, it works as well as tamoxifen.

2 Jun 2015

Stable IV formulation to treat systemic susceptible and resistant Gram-positive hospital-acquired infections

MGB Biopharma, a biopharmaceutical company developing a truly novel class of anti-infectives, to address the major global problem of antibiotic resistance - announces that it has developed a stable intravenous (IV) formulation of MGB-BP-3, designed for the treatment of systemic susceptible and resistant Gram-positive hospital-acquired infections.

2 Jun 2015

Two new groups of viruses discovered within Bunyavirus family in Ivory Coast tropical forest

Researchers at the University of Bonn and the German Center for Infection Research (DZIF) have discovered two new groups of viruses within the Bunyavirus family in the tropical forest of Ivory Coast. Previously only five groups responsible for serious illnesses in humans and animals were known.

2 Jun 2015

Study finds link between pyrethroid pesticide exposure and ADHD in children, teens

A new study links a commonly used household pesticide with attention deficit hyperactivity disorder (ADHD) in children and young teens.

2 Jun 2015

Consumer Reports announces commitment to help wipe out 'superbugs'

Consumer Reports, the world's largest and most trusted nonprofit consumer organization, today announced its commitment to help wipe out antibiotic-resistant bacteria or "superbugs." Infections related to the use of antibiotics sicken about 2.25 million Americans each year and kill 37,000, according to the Centers for Disease Control and Prevention.

2 Jun 2015

BioStructures announces first application of Prohesion surgical wound technology

BioStructures, LLC, a privately held orthobiologics company, announced today the first application of Prohesion, its new surgical wound technology.

2 Jun 2015

Veritas Genetics introduces genetic screen for hereditary breast and ovarian cancer risk

Boston-based Veritas Genetics is launching its mission to disrupt the genetic testing industry and bring personalized medicine and prevention to the forefront, allowing individuals to take more control of their health.

2 Jun 2015

Gaumard Scientific's installations of Victoria birthing simulator continue at rapid pace in the U.S.

Gaumard Scientific Company today announced that its U.S. installations of the Victoria birthing simulator continue at a rapid pace as more health care educators select what is the industry's most advanced maternal-fetal simulator for their teaching purposes. Victoria installations now span 24 states in all regions and reflect the demand for advanced fully tetherless and wireless technology that Gaumard offers.

2 Jun 2015

New York State lawmakers lend critical helping hand to CARE Act

New York State lawmakers lent a critical helping hand today to millions of family caregivers and those for whom they care by giving final legislative passage to the CARE Act, top priority legislation for AARP that will help New Yorkers age safely at home.

2 Jun 2015

New York Eye and Ear Infirmary of Mount Sinai observes June 1st as World Orthoptics Day

New York Eye and Ear Infirmary of Mount Sinai joins with the International Orthoptic Association to observe June 1st as World Orthoptics Day.

2 Jun 2015

NCCN to host policy summit on emerging issues in tissue allocation

Tissue allocation is a growing issue of concern for many researchers due, in part, to expanding research interests in precision medicine. The increased demand by pharmaceutical and biotech companies for patient tissue specimens collected for clinical care and trials presents clinical, ethical, and legal issues.

2 Jun 2015

Genesis Rehab Services forms groundbreaking partnership with Zhejiang Bang-Er Medical Group

Genesis Rehab Services, a division of Genesis HealthCare, one of the nation's largest providers of post-acute care, today announced a groundbreaking partnership with Zhejiang Bang-Er Medical Group, an orthopedic hospital system in China.

2 Jun 2015

Hospital News and Research

Scientists identify gene mutation that causes color blindness

Researchers explore association between SSRI exposure in late pregnancy and risk of PPHN

NW Bio releases promising new data on DCVax-Direct Phase I trial for inoperable solid tumors

Elusys’ Anthim BLA to treat inhalational anthrax accepted for review by the FDA

Vitamin D and calcium supplements may not help relieve menopausal symptoms, reveals study

Intermountain Precision Genomics: Precision medicine can benefit advanced cancer patients without increasing costs

ESMO-MCBS tool will help oncology clinicians evaluate most effective anti-cancer medicines

ASCO 2015: Novartis presents data on Zykadia and Tafinlar studies for non-small cell lung cancer

New treatment option for postmenopausal women with non-invasive breast cancer

Stable IV formulation to treat systemic susceptible and resistant Gram-positive hospital-acquired infections

Two new groups of viruses discovered within Bunyavirus family in Ivory Coast tropical forest

Study finds link between pyrethroid pesticide exposure and ADHD in children, teens

Consumer Reports announces commitment to help wipe out 'superbugs'

BioStructures announces first application of Prohesion surgical wound technology

Veritas Genetics introduces genetic screen for hereditary breast and ovarian cancer risk

Gaumard Scientific's installations of Victoria birthing simulator continue at rapid pace in the U.S.

New York State lawmakers lend critical helping hand to CARE Act

New York Eye and Ear Infirmary of Mount Sinai observes June 1st as World Orthoptics Day

NCCN to host policy summit on emerging issues in tissue allocation

Genesis Rehab Services forms groundbreaking partnership with Zhejiang Bang-Er Medical Group

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

Latest News